Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CD47 prevents the elimination of diseased fibroblasts in scleroderma

JCI Insight(2020)10.1172/jci.insight.140458Source: DataRank Database

CD47 prevents the elimination of diseased fibroblasts in scleroderma is a research paper published in JCI Insight (2020). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 3.20)OA: goldTopics (79)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Lu Cui ORCID,Megan E. King ORCID,Tim Chai,Claire Muscat,Leland W.K. Chung ORCID

Live enrichment

PubMed:32814713 PMC:PMC7455137 OpenAlex:https://openalex.org/W3071761920

Deutsche Forschungsgemeinschaft

Grant: LE 4087/1-2

National Institutes of Health

Grant: 1K08HL143143-03

NHLBI NIH HHS

Grant: K08 HL143143

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

National Institutes of Health

Grant: 1K08HL143143-01

Immune Checkpoint Inhibitors as Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis

Scleroderma Research Foundation

FWCI

3.20

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

goldLicense: cc-by

journalhttp://insight.jci.org/articles/view/140458/files/pdf

publisherhttp://insight.jci.org/articles/view/140458/files/pdf

publisherhttps://insight.jci.org/articles/view/140458/files/pdf

journalhttps://doi.org/10.1172/jci.insight.140458

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32814713

Fields of Study

Systemic Sclerosis and Related DiseasesMast cells and histamineDermatologic Treatments and Research03 medical and health sciences0302 clinical medicineAnilidesAnimalsCD47 AntigenCell Self RenewalCells, CulturedDipeptidyl Peptidase 4Disease Models, AnimalFemaleFibroblastsHumansImmune Checkpoint InhibitorsImmunotherapyInterleukin-6LungMaleMice, Inbred StrainsProto-Oncogene Proteins c-junPyridinesScleroderma, SystemicInterleukin-6 Inhibitors

MeSH Terms

Cell Self RenewalImmune Checkpoint InhibitorsInterleukin-6 InhibitorsAnilidesAnimalsCells, CulturedDisease Models, AnimalFemaleFibroblastsHumansImmunotherapyLungMaleMice, Inbred StrainsPyridinesScleroderma, SystemicInterleukin-6Proto-Oncogene Proteins c-junDipeptidyl Peptidase 4CD47 Antigen

Keywords

CD47Scleroderma (fungus)FibrosisIn vivoCancer researchMedicineImmune systemImmunologyPathologyBiologyImmunotherapyAutoimmunityDermatologyMaleProto-Oncogene Proteins c-junPyridinesDipeptidyl Peptidase 4CD47 AntigenMice, Inbred StrainsInterleukin-6 InhibitorsAnimalsHumansAnilidesCell Self RenewalImmune Checkpoint InhibitorsLungCells, CulturedScleroderma, SystemicInterleukin-6RFibroblastsDisease Models, AnimalFemaleResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

CD47 prevents the elimination of diseased fibroblasts in scleroderma

FAIR Checklist

Authors (10)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)